Unknown

Dataset Information

0

L-arginine as a potential GLP-1-mediated immunomodulator of Th17-related cytokines in people with obesity and asthma.


ABSTRACT: Obesity is considered as a risk factor for COVID-19 with insulin resistance and increased production of inflammatory cytokines as likely mechanisms. Glucagon-like peptide-1 (GLP-1) agonists and inhaled nitric oxide are proposed therapeutic approaches to treat COVID-19 because of their broad anti-inflammatory effects. One approach that might augment GLP-1 levels would be dietary supplementation with L-arginine. Beyond cytokines, multiple studies have started to investigate the relationship between new-onset diabetes and COVID-19. In a posthoc analysis of a randomized, placebo-controlled human clinical trial of L-arginine supplementation in people with asthma and predominantly with obesity, the results showed that 12 weeks of continuous L-arginine supplementation significantly decreased the level of IL-21 (p = 0.02) and increased the level of insulin (p = 0.02). A high arginine level and arginine/ADMA ratio were significantly associated with lower CCL-20 and TNF-α levels. The study also showed that L-arginine supplementation reduces cytokine levels and improves insulin deficiency or resistance, both are two big risk factors for COVID-19 severity and mortality. Given its safety profile and ease of accessibility, L-arginine is an attractive potential therapeutic option that allows for a cost-effective way to improve outcomes in patients. An expedition of further investigation or clinical trials to test these hypotheses is needed.

SUBMITTER: Liao SY 

PROVIDER: S-EPMC8170586 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC3855890 | biostudies-other
| S-EPMC3886588 | biostudies-literature
| S-EPMC4688084 | biostudies-literature
| S-EPMC5686108 | biostudies-literature
| S-EPMC7108896 | biostudies-literature
| S-EPMC3570651 | biostudies-literature
2020-02-27 | GSE141194 | GEO
2020-02-27 | GSE141196 | GEO
| S-EPMC6599430 | biostudies-literature
| S-EPMC7406254 | biostudies-literature